scispace - formally typeset
Search or ask a question
Institution

University of Arkansas for Medical Sciences

EducationLittle Rock, Arkansas, United States
About: University of Arkansas for Medical Sciences is a education organization based out in Little Rock, Arkansas, United States. It is known for research contribution in the topics: Population & Health care. The organization has 14077 authors who have published 26012 publications receiving 973592 citations. The organization is also known as: UAMS.


Papers
More filters
Journal ArticleDOI
TL;DR: Findings provide a mechanistic explanation for the recent evidence that peroxisome proliferator-activated receptor isoform gamma activation is a negative regulator of bone mass and suggest that the increased production of oxidized fatty acids with age may indeed be an important mechanism for age-related osteoporosis in humans.
Abstract: Because osteoblasts and marrow adipocytes are derived from a common mesenchymal progenitor, increased adipogenesis may occur at the expense of osteoblasts, leading to bone loss. Our previous in vitro studies indicated that activation of the proadipogenic transcription factor peroxisome proliferator-activated receptor isoform γ 2 with rosiglitazone suppressed osteoblast differentiation. Here, we show that 5-month-old Swiss-Webster mice receiving rosiglitazone for 28 d exhibited bone loss associated with an increase in marrow adipocytes, a decrease in the ratio of osteoblasts to osteoclasts, a reduction in bone formation rate, and a reduction in wall width—an index of the amount of bone formed by each team of osteoblasts. Rosiglitazone had no effect on the number of early osteoblast or osteoclast progenitors, or on osteoblast life span, but decreased the expression of the key osteoblastogenic transcription factors Runx2 and Osterix in cultures of marrow-derived mesenchymal progenitors. These effects were as...

438 citations

Journal ArticleDOI
TL;DR: A review of the legal status of common synthetic cannabinoids detected in Spice and analytical procedures used to test Spice products and human specimens collected under a variety of clinical circumstances is provided in this paper.
Abstract: “K2” and “Spice” drugs (collectively hereafter referred to as Spice) represent a relatively new class of designer drugs that have recently emerged as popular alternatives to marijuana, otherwise characterized as “legal highs”. These drugs are readily available on the Internet and sold in many head shops and convenience stores under the disguise of innocuous products like herbal blends, incense, or air fresheners. Although package labels indicate “not for human consumption”, the number of intoxicated people presenting to emergency departments is dramatically increasing. The lack of validated and standardized human testing procedures and an endless supply of potential drugs of abuse are primary reasons why researchers find it difficult to fully characterize clinical consequences associated with Spice. While the exact chemical composition and toxicology of Spice remains to be determined, there is mounting evidence identifying several synthetic cannabinoids as causative agents responsible for psychoactive and adverse physical effects. This review provides updates of the legal status of common synthetic cannabinoids detected in Spice and analytical procedures used to test Spice products and human specimens collected under a variety of clinical circumstances. The pharmacological and toxicological consequences of synthetic cannabinoid abuse are also reviewed to provide a future perspective on potential short- and long-term implications.

437 citations

Journal ArticleDOI
TL;DR: In this article, a cDNA clone encoding a third peanut allergen, Ara h 3, was found within the primary sequence, with no obvious sequence motif shared by the peptides.
Abstract: Peanut allergy is a significant IgE-mediated health problem because of the increased prevalence, potential severity, and chronicity of the reaction. Following our characterization of the two peanut allergens Ara h 1 and Ara h 2, we have isolated a cDNA clone encoding a third peanut allergen, Ara h 3. The deduced amino acid sequence of Ara h 3 shows homology to 11S seed-storage proteins. The recombinant form of this protein was expressed in a bacterial system and was recognized by serum IgE from approximately 45% of our peanut-allergic patient population. Serum IgE from these patients and overlapping, synthetic peptides were used to map the linear, IgE-binding epitopes of Ara h 3. Four epitopes, between 10 and 15 amino acids in length, were found within the primary sequence, with no obvious sequence motif shared by the peptides. One epitope is recognized by all Ara h 3-allergic patients. Mutational analysis of the epitopes revealed that single amino acid changes within these peptides could lead to a reduction or loss of IgE binding. By determining which amino acids are critical for IgE binding, it might be possible to alter the Ara h 3 cDNA to encode a protein with a reduced IgE-binding capacity. These results will enable the design of improved diagnostic and therapeutic approaches for food-hypersensitivity reactions.

435 citations


Authors

Showing all 14187 results

NameH-indexPapersCitations
Hagop M. Kantarjian2043708210208
Yusuke Nakamura1792076160313
Kenneth C. Anderson1781138126072
David R. Williams1782034138789
Yang Yang1712644153049
John E. Morley154137797021
Jeffrey L. Cummings148833116067
Hugh A. Sampson14781676492
Michael J. Keating140116976353
Kristine Yaffe13679472250
Nancy J. Cox135778109195
Stephen W. Scherer13568585752
Nikhil C. Munshi13490667349
Siamon Gordon13142077948
Jian-Guo Bian128121980964
Network Information
Related Institutions (5)
University of Alabama at Birmingham
86.7K papers, 3.9M citations

96% related

Johns Hopkins University School of Medicine
79.2K papers, 4.7M citations

96% related

University of California, San Francisco
186.2K papers, 12M citations

96% related

Baylor College of Medicine
94.8K papers, 5M citations

96% related

Emory University
122.4K papers, 6M citations

95% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202332
2022156
20211,609
20201,410
20191,214
20181,251